Massive growth of paratesticular myxoid liposarcoma recurrence and inguinal metastases following scrotal violation: A case report
Keywords:
Myxoid liposarcoma, paratesticular tumor, scrotal violation, scrotal massAbstract
Paratesticular myxoid liposarcomas are exceedingly uncommon soft tissue tumor, comprising merely 3.3% of all liposarcomas in paratesticle. The primary treatment involves total surgical removal with orchiectomy performed through an inguinal incision. Even though radical orchiectomy is still the best treatment to date, recurrence is still inevitable. There is possibility of tumor recurrence and metastasis due to scrotal violation. Trans-scrotal approach of orchiectomy increased the possibility of local recurrence and possible spread by allowing the cancerous cells to leak into the adjacent tissues. We discuss the clinical presentation of the case, the therapeutic management, and the possible complications after scrotal violation of prior removal surgery. We report a case of a 69-year-old man with painful recurrent scrotal tumor along with massive growth and spread to the spermatic cord and inguinal region after right orchiectomy with trans scrotal approach one year earlier. The tumors were 23 x 25 x 8 cm for the inguinal tumor, 13 x 9 x 7 cm with ulcerative surface for the scrotal tumor, and 12 x 6.5 x 5 cm for the spermatic cord tumor. Our patient then had wide excision tumor surgery with a radical lymphadenectomy. Similar cases of recurrent paratesticular myxoid liposarcoma have been reported; however, the recurrence occurred over a year and no metastases had been found. In our case, the recurrent tumor had significant development rapidly within a year after scrotal violation and was also found to have already metastasized to the inguinal region. Massive recurrence tumor growth and spread in paratesticular liposarcoma following orchiectomy is rarely heard of. Surgical treatment is still the preferred treatment to date, but local recurrence and metastasise somehow is inevitable. Tumor recurrence and spread hopefully can be prevented by proper diagnosis and surgical management of the tumors; high ligation of the cord, inguinal approach and ensure negative margin of tumors. This case report also highlights the significance of avoiding scrotal violations to prevent tumor seeding to adjacent sites, thereby reducing patient morbidity and mortality
Downloads
Metrics
References
Papageorgiou MS, Dadakas G, Donev K. Liposarcoma of the Spermatic Cord: A Case Report. Case Rep Med. 2011 Sep 25;2011:e197584.
Zeitouni L, Rahman S, Chan K, Thway K, Arora A, Hammadeh MY. A case report of uncommon paratesticular liposarcoma of spermatic cord presenting as a scrotal mass. Urol Case Rep. 2020 Nov 1;33:101416.
Sbaraglia M, Bellan E, Dei Tos AP. The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives. Pathologica. 2020 Nov 3;113(2):70–84.
Ayari Y, Sellami A, Boussaffa H, Zehani A, Ben Rhouma S, Nouira Y. About a case of paratesticular myxoid liposarcoma. Urol Case Rep. 2018 Nov 1;21:27–8.
Hemalatha A, Kumar BD, Rupashree S, Sumanth D, Vani D. Paratesticular myxoid liposarcoma: a case report. Indian J Pathol Microbiol [Internet]. 2007 Apr 1 [cited 2024 Feb 19]; Available from: https://www.semanticscholar.org/paper/Paratesticular-myxoid-liposarcoma%3A-a-case-report.-Hemalatha-Kumar/a32513a101239da888fe799ae4f67307b5538d2d
Favela JG, Argo MB, Huerta S. Well-differentiated liposarcoma of spermatic cord presenting as recurrent inguinal hernia: a case report. Ame Case Rep [Internet]. 2024 Jul 30 [cited 2025 Mar 2];8(0). Available from: https://acr.amegroups.org/article/view/9369
Qu G, Zhang C, Tian Z, Yao W. Diagnosis and treatment of myxoid liposarcoma. Curr Treat Options Oncol. 2024 Oct 1;25(10):1289–96.
Potkrajcic V, Zschiegner M, Niyazi M, Warm V, Thiel JT, Frantz S, et al. Myxoid liposarcoma: treatment outcomes, metastatic pattern and volumetric analysis. Strahlenther Onkol [Internet]. 2025 Feb 3 [cited 2025 Mar 2]; Available from: https://doi.org/10.1007/s00066-025-02366-3
Chandrasekaran Y, Amitkumar K, Elamaran A, Sudalaimuthu M, Kumaran S, Chandrasekaran Y, et al. Myxoid pleomorphic liposarcoma of the spermatic cord: a rare entity at a rare site. Cureus [Internet]. 2024 Jul 28 [cited 2025 Mar 2];16(7). Available from: https://www.cureus.com/articles/275244-myxoid-pleomorphic-liposarcoma-of-the-spermatic-cord-a-rare-entity-at-a-rare-site
Homsy P, Böhling T, Seitsonen A, Sampo M, Tukiainen E, Blomqvist C. Patterns of metastatic recurrence of genetically confirmed myxoid liposarcoma. Ann Surg Oncol. 2023 Jul 1;30(7):4489–97.
Hayes AJ, Nixon IF, Strauss DC, Seddon BM, Desai A, Benson C, et al. UK guidelines for the management of soft tissue sarcomas. Br J Cancer. 2025 Jan;132(1):11–31.
Ipponi E, Bechini E, Cordoni M, Gentili F, Cosseddu F, D’Arienzo A, et al. Myxoid liposarcomas of the thigh: pre-operative presentation, clinical outcomes, and functional results of surgical treatment. Health Care (Don Mills). 2024 Jan;12(17):1718.
Capelouto CC, Clark PE, Ransil BJ, Loughlin KR. Original articles: testis cancer: a review of scrotal violation in testicular cancer: is adjuvant local therapy necessary? J Urol [Internet]. 1995 Mar [cited 2025 Mar 2]; Available from: https://www.auajournals.org/doi/10.1016/S0022-5347%2801%2967617-1
Patel HD, Gupta M, Cheaib JG, Sharma R, Zhang A, Bass EB, et al. Testis-sparing surgery and scrotal violation for testicular masses suspicious for malignancy: a systematic review and meta-analysis. Urol Oncol Semin Orig Investig. 2020 May 1;38(5):344–53.
Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D, et al. The CARE guidelines: consensus-based clinical case reporting guideline development. J Med Case Reports. 2013 Sep 10;7(1):223.
De Nardi P, Bissolati M, Cristallo M, Staudacher C. Recurrent giant liposarcoma of the spermatic cord. Urology. 2012 Jan;79(1):113–4.
Shah AH, Alshebani HM, Alamori I. Paratesticular Liposarcoma: A Case Report And Review Of Literature. J Cancer Ther Res [Internet]. 2021 Jan 1 [cited 2024 Feb 21];1(1). Available from: https://www.genesispub.org/j-can-ther-and-res/-a-case-report-and-review-of-literature
Hua R, Zhao L, Xu L, Sun J, Huang J, Hua Q. Recurrent paratesticular giant liposarcoma: A case report and literature review. Front Surg [Internet]. 2023 [cited 2024 Feb 21];10. Available from: https://www.frontiersin.org/articles/10.3389/fsurg.2023.1171952
Guo S, Xu Y, Qian F, Ma J, Wang S, Chen P, et al. A recurrent giant retroperitoneal myxoid liposarcoma: a case report and literature review. Transl Cancer Res [Internet]. 2019 Nov [cited 2024 Feb 21];8(7). Available from: https://tcr.amegroups.org/article/view/33268
Mondaini N, Palli D, Saieva C, Nesi G, Franchi A, Ponchietti R, et al. Clinical Characteristics and Overall Survival in Genitourinary Sarcomas Treated with Curative Intent: A Multicenter Study. Eur Urol. 2005 Apr 1;47(4):468–73.
SONG CH, CHAI FY, SAUKANI MFM, SINGH H, JIFFRE D. Management and Prevention of Recurrent Paratesticular Liposarcoma. Malays J Med Sci MJMS. 2013 Jul;20(4):95–7.
Dotan ZA, Tal R, Golijanin D, Snyder ME, Antonescu C, Brennan MF, et al. Adult Genitourinary Sarcoma: The 25-Year Memorial Sloan-Kettering Experience. J Urol. 2006 Nov;176(5):2033–9.
Ballo MT, Zagars GK, Pisters PW, Feig BW, Patel SR, von Eschenbach AC. Spermatic cord sarcoma: outcome, patterns of failure and management. J Urol. 2001 Oct;166(4):1306–10.
Rodríguez D, Olumi AF. Management of spermatic cord tumors: a rare urologic malignancy. Ther Adv Urol. 2012 Dec 1;4(6):325–34.
Blitzer PH, Dosoretz DE, Proppe KH, Shipley WU. Treatment of malignant tumors of the spermatic cord: a study of 10 cases and a review of the literature. J Urol. 1981 Nov;126(5):611–4.
Sogani PC, Grabstald H, Whitmore WF. Spermatic cord sarcoma in adults. J Urol. 1978 Sep;120(3):301–5.
Chalouhy C, Ruck JM, Moukarzel M, Jourdi R, Dagher N, Philosophe B. Current management of liposarcoma of the spermatic cord: A case report and review of the literature. Mol Clin Oncol. 2017 Mar 1;6(3):438–40.
Jeremić D, Maletin M, Vojinov S, Levakov I, Grbić D, Lakić T, et al. LIPOSARCOMA OF THE SPERMATIC CORD – DIAGNOSTIC AND THERAPEUTIC ISSUE. Acta Clin Croat. 2021 Mar;60(1):50–4.
Kamitani R, Matsumoto K, Takeda T, Mizuno R, Oya M. Optimal treatment strategy for paratesticular liposarcoma: retrospective analysis of 265 reported cases. Int J Clin Oncol. 2020 Dec;25(12):2099–106.
Lee HS, Yu JI, Lim DH, Kim SJ. Retroperitoneal liposarcoma: the role of adjuvant radiation therapy and the prognostic factors. Radiat Oncol J. 2016 Sep;34(3):216–22.
Tuzzato G, Laranga R, Ostetto F, Bubbico E, Vara G, Bianchi G. Primary High-Grade Myxoid Liposarcoma of the Extremities: Prognostic Factors and Metastatic Pattern. Cancers. 2022 May 27;14(11):2657.
Aki FT, Bilen CY, Tekin MI, Ozen H. Is scrotal violation per se a risk factor for local relapse and metastases in stage I nonseminomatous testicular cancer? Urology. 2000 Sep 1;56(3):459–62.
Capelouto CC, Clark PE, Ransil BJ, Loughlin KR. A review of scrotal violation in testicular cancer: is adjuvant local therapy necessary? J Urol. 1995 Mar;153(3 Pt 2):981–5.
Dürr HR, Rauh J, Baur-Melnyk A, Knösel T, Lindner L, Roeder F, et al. Myxoid liposarcoma: local relapse and metastatic pattern in 43 patients. BMC Cancer. 2018 Mar 20;18:304.
Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, et al. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol. 2018 Oct 1;29(Suppl 4):iv51–67.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
